[干预效应和调节MiR-155在患有血液凝固功能障碍的年轻大鼠上的机制]

Ya-Jing Zhang1, Er-Wei Yuan1, Hai-Xin Qu1

  • 1Department of Neonatology,The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China.

概括

降低调节的miR-155通过调节关键因素和抑制炎症来改善大鼠的凝血. 这表明miR-155通过HMGB1-RAGE/TLRs-NF-κB通路在凝血病中起作用.